1. 382 PHASE-III Randomized monocentric controlled trial comparing clinical and cost-effectiveness analysis of botulinum toxin uterine injections versus placebo for severe dysmenorrhea and chronic pelvic pain from uterine origin after standard therapeutic failure. (March 2022) Authors: Bautrant, E.; Lévêque, C.; Santos, M.; Kouame, J.; Franké, O.; Amiel, C.; Bensousan, T.; Thiers-Bautrant, D.; Siani, C. Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 270(2022) Page Start: e102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomised controlled trial to validate the efficacy of a cianoacrylate based sealing glue to reduce axillary seroma: GLUBREAST Trial. (March 2019) Authors: Esposito, E.; Siani, C.; Avino, F.; Donzelli, I.; Fucito, A.; Melucci, M.T.; Saponara, R.; Tortoriello, R.; Rinaldo, M.; Giacomo, R.D. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗